First Commercial Use of the HAART 300 in US

BioStable Science & Engineering Announces announced today the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia. Dr. Lawrence Wei, Dr. Vinay Badhwar and Dr. J. Scott Rankin, were the collaborating surgeons for the procedures.

2018-12-07T17:44:49-06:00June 14th, 2017|Press Release|

HAART 300 Receives FDA Clearance

BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device designed for aortic valve repair.

2018-12-07T17:49:56-06:00March 22nd, 2017|Press Release|
Go to Top